FDA Gives Pfizer Vax Priority Review For Full Approval

CNN reports:

Pfizer and BioNTech said Friday that the US Food and Drug Administration has granted priority review designation to their application for full approval of their Covid-19 vaccine, and an FDA official said the decision will come “soon”.

The FDA official told CNN on Friday that a decision on full approval is likely to come within two months. The agency considers this matter a priority, said the official, who asked not to be named because they were not authorized to speak publicly on the matter.

Full approval could have an impact on vaccine mandates — several schools and business have suggested they would consider mandating Covid-19 vaccines once they are approved. It may also help sway skeptics hesitant to get the vaccines now.

Read the full article.